[Changes in clinical intervention studies: when the wellbeing of the patients takes precedence].
Flórez
H
H
Casanova
P
P
D000959:Antihypertensive Agents / Q000627:therapeutic use; D002839:Chromans / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000379:methods* / Q000592:standards; D048909:Diabetes Complications; D004656:Enalapril / Q000627:therapeutic use; D004992:Ethics, Medical; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008687:Metformin / Q000627:therapeutic use; D015337:Multicenter Studies as Topic; D015737:Nisoldipine / Q000627:therapeutic use; D011236:Prediabetic State / Q000188:drug therapy; D011446:Prospective Studies; D013844:Thiazoles / Q000627:therapeutic use; D045162:Thiazolidinediones; D017211:Treatment Failure; D000077288:Troglitazone
D000959:Antihypertensive Agents; D002839:Chromans; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D015737:Nisoldipine; D004656:Enalapril; D008687:Metformin; D000077288:Troglitazone
Cambios en los estudios de intervención clínica: cuando el bienestar de los pacientes se impone.